https://www.selleckchem.com/pr....oducts/PD-0332991.ht
Primary surgery was selected in patients with low score RS (18), and NET was preferred in patients with intermediate or high RS (18). NET was preferred over NAC in patients with low RS (18). This study shows that CNB ODx RS helps guide treatment decisions in a neoadjuvant setting along with other contributing factors such as the presence of pathogenic mutations, node positivity, patient age, and comorbidities. The use of ODx on CNB is furthermore valuable in the midst of the COVID-19 pandemic for early breast cancer patie
إعجاب
علق
شارك
